Key takeaway: Dharmaj Crop Guard Limited reported a revenue of Rs. 1138 crores for FY’26, reflecting a 20% year-on-year growth, with Q4 FY’26 revenue at Rs. 234 crores, an 11% increase year-on-year. Management highlighted a strong overall financial performance despite challenges such as uneven monsoon and disruptions from the West Asia crisis. EBITDA for the full year stood at Rs. 101 crores, a 34% year-on-year growth, while net profit reached Rs. 55 crores, up 57% year-on-year. The domestic institutional segment grew 15% year-on-year, but branded formulations saw muted growth of 3%. Management noted that the technical plant achieved PBT level break-even and that a new herbicide facility is on track for commissioning in Q3 FY’27. Management set a goal of 18% to 20% overall top-line growth for FY’27, focusing on scaling up utilization and improving product mix.

Key takeaway: Dharmaj Crop Guard Limited's investor presentation for the financial year and fourth quarter ended March 31, 2026, reported a revenue growth of 20% year-over-year (YOY) for FY26, reaching ₹11,380 million. The presentation highlighted an 11% YOY revenue growth for Q4FY26, despite a higher base from Q4FY25. Management noted significant improvements in profitability, with EBITDA increasing by 34% YOY to ₹1,005 million and net profit rising by 57% YOY to ₹547 million. The Domestic Institutional segment showed a healthy growth of 15% YOY, while the Branded Formulations vertical experienced a modest growth of 3% YOY. The company successfully achieved break-even at the profit before tax level in its Technicals unit. Management emphasized the importance of securing additional inventories to navigate challenges in input availability and pricing, particularly in light of the West Asia crisis. The presentation also outlined ongoing projects and strategic goals for future growth.

Key takeaway: Dharmaj Crop Guard Limited's investor presentation for the third quarter and nine months ended December 31, 2025, reported a 9% year-over-year revenue growth for Q3 and a 22% growth for the nine-month period. The presentation highlighted a decline in EBITDA margins for Q3, attributed to a lower sales mix of formulations and a one-time provision related to labor code amendments. The Active Ingredients segment showed strong performance, with a 59% year-over-year growth. Management noted that the company is on track with a new CAPEX project for a dedicated Herbicides Formulations Unit in Kerala, aimed at enhancing capacity and throughput. The presentation also mentioned an increase in retail touchpoints and product registrations, indicating ongoing efforts to strengthen the product portfolio and market presence.